Sry‐related high‐mobility‐group/HMG box 10 (SOX10) as a sensitive marker for triple‐negative breast cancer

Shirley K. Jamidi, Jintao Hu, Chaiwat Aphivatanasiri, +6

Histopathology

Combining Analysis of Tumor-infiltrating Lymphocytes (TIL) and PD-L1 Refined the Prognostication of Breast Cancer Subtypes

Yun‐Bi Ni, Julia Y. Tsang, Yan Shao, +4

The Oncologist

The significance of highlighting the oestrogen receptor low category in breast cancer

Ivan K. Poon, Julia Y. Tsang, Joshua Li, +3

British Journal of Cancer

Combined SOX10 GATA3 is most sensitive in detecting primary and metastatic breast cancers: a comparative study of breast markers in multiple tumors

Chaiwat Aphivatanasiri, Joshua Li, Ronald Chan, +11

Breast Cancer Research and Treatment

Breast OncologyOncologyCancer DetectionMedicineSox10 Gata3 +11

The Clinical Significance of Neuroendocrine Features in Invasive Breast Carcinomas

Billy Shui‐Wun Lai, Julia Y. Tsang, Ivan K. Poon, +6

The Oncologist

INSM1 is a novel prognostic neuroendocrine marker for luminal B breast cancer

Huda Razvi, Julia Y. Tsang, Ivan K. Poon, +4

Pathology

Breast OncologyMedicineNeuroendocrine DisorderPathologyBreast Cancer +5

A comparative study of diagnostic accuracy in 3026 pleural biopsies and matched pleural effusion cytology with clinical correlation

Ivan K. Poon, Ronald Chan, Joseph Choi, +7

Cancer Medicine

The International Academy of Cytology Yokohama System for Reporting Breast Cytopathology showed improved diagnostic accuracy

Monalyn Marabi, Chaiwat Aphivatanasiri, Shirley K. Jamidi, +6

Cancer Cytopathology

Analysis of recurrent molecular alterations in phyllodes tumour of breast: insights into prognosis and pathogenesis

Julia Y. Tsang, Yan Shao, Ivan K. Poon, +5

Pathology

Tumor BiologyRecurrent Molecular AlterationsBreast OncologyMedicinePathology +6

Co-expression of HLA-I loci improved prognostication in HER2+ breast cancers

Julia Y. Tsang, Chun-Sing Ho, Yun‐Bi Ni, +7

Cancer Immunology Immunotherapy

Breast OncologyMedicineCancer GenomicsHla-i LociBreast Cancer +6